These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 19447939

  • 1. Clinical correlates of self-reported physical health status in systemic sclerosis.
    Hudson M, Steele R, Lu Y, Thombs BD, Panopalis P, Baron M, Canadian Scleroderma Research Group.
    J Rheumatol; 2009 Jun; 36(6):1226-9. PubMed ID: 19447939
    [Abstract] [Full Text] [Related]

  • 2. Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II.
    Hudson M, Thombs BD, Steele R, Watterson R, Taillefer S, Baron M, Canadian Scleroderma Research Group Investigators.
    Arthritis Rheum; 2008 Feb 15; 59(2):279-84. PubMed ID: 18240196
    [Abstract] [Full Text] [Related]

  • 3. Work disability in systemic sclerosis.
    Hudson M, Steele R, Lu Y, Thombs BD, Canadian Scleroderma Research Group, Baron M.
    J Rheumatol; 2009 Nov 15; 36(11):2481-6. PubMed ID: 19797513
    [Abstract] [Full Text] [Related]

  • 4. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F, Poiraudeau S, Berezné A, Baubet T, Le-Guern V, Cabane J, Guillevin L, Revel M, Fermanian J, Mouthon L.
    Arthritis Rheum; 2007 Feb 15; 57(1):94-102. PubMed ID: 17266096
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
    Johnson SR, Glaman DD, Schentag CT, Lee P.
    J Rheumatol; 2006 Jun 15; 33(6):1117-22. PubMed ID: 16622903
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis.
    Malcarne VL, Hansdottir I, McKinney A, Upchurch R, Greenbergs HL, Henstorf GH, Furst DE, Clements PJ, Weisman MH.
    J Rheumatol; 2007 Feb 15; 34(2):359-67. PubMed ID: 17304659
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
    Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Korn JH, Merkel PA, Rothfield N, Wigley FM, Moreland LW, Silver R, Steen VD, Weisman M, Mayes MD, Collier DH, Medsger TA, Seibold JR, Relaxin Study Group, Scleroderma Clinical Trials Consortium.
    J Rheumatol; 2005 May 15; 32(5):832-40. PubMed ID: 15868618
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di Matteo L, Scendoni P, Grassi W, Italian Multicentre Osteoporotic Fracture Study Group.
    J Rheumatol; 2007 Jul 15; 34(7):1551-60. PubMed ID: 17516618
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
    Khanna D, Yan X, Tashkin DP, Furst DE, Elashoff R, Roth MD, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Clements PJ, Scleroderma Lung Study Group.
    Arthritis Rheum; 2007 May 15; 56(5):1676-84. PubMed ID: 17469162
    [Abstract] [Full Text] [Related]

  • 18. The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.
    Sekhon S, Pope J, Canadian Scleroderma Research Group, Baron M.
    J Rheumatol; 2010 Mar 15; 37(3):591-8. PubMed ID: 20080913
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
    Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Seibold JR.
    Arthritis Rheum; 2001 Mar 15; 44(3):653-61. PubMed ID: 11263780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.